Vanguard’s India portfolio has surged 53% to Rs 65,897 crore, with 10 key stocks rallying up to 90% in FY26, highlighting its sharp stock-picking strategy.

Time Technoplast, a polymer product maker, is raising funds through a qualified institutional placement. The company plans to raise approximately ₹800 crore. This move will dilute nearly 8.8% of its equity. The issue opens on November 6 at a floor price of ₹211.7 per share. The indicative issue price is ₹201.12 per share.

In a remarkable financial turn, Torrent Pharmaceuticals has disclosed a staggering 30% rise in after-tax profit for the September quarter, reaching ₹591 crore. This impressive growth is attributed to thriving sales in various markets, which escalated their total revenue to ₹3,302 crore.

HSBC sees India as a safe haven amid global AI market excitement. Indian stocks are currently underrepresented in emerging market portfolios. Increased investment could significantly benefit India. HSBC is positive on Indian equities, setting a 2026 Sensex target of 94,000. Valuations are now less of a concern. India offers value compared to Chinese equities.

Groww’s Rs 6,632 crore IPO saw strong demand, with 17.6 times overall subscription. Investors can check allotment status via MUFG Intime India or BSE. Refunds and share credits begin November 11, with listing on BSE and NSE scheduled for November 12.

Grey market trends indicate potential listing gains of 4–22% for nine upcoming IPOs next week, including Lenskart, PhysicsWallah, and Groww, reflecting strong investor interest and market momentum across new-age and SME listings.

InCred Equities has reshuffled its high-conviction stock list, adding Tata Steel, VRL Logistics, and GE Vernova T&D, while dropping Bajaj Auto, Skipper, and NTPC amid festive demand and GST-driven consumption recovery.

India is a global growth engine, defying economic norms. Foreigners hold majority stakes in top companies, and the nation welcomes global tech giants. Despite significant gold imports, India is a leader in space exploration and AI accessibility. Its healthcare sector showcases both shortages and global dominance in generic drug manufacturing, proving India s unique, paradoxical strength.

T​he BSE Smallcap index fell 1.5% this week, with 76% of stocks in the red. However, 20 smallcap stocks bucked the trend, delivering weekly gains up to 56%, highlighting strong investor interest and selective bullish momentum in the segment.

Nine BSE200 stocks, including Tata Elxsi and NTPC, fell for five consecutive sessions, highlighting sustained pressure amid a 1.4% Sensex decline.